Previous investors were led by Grand Challenges Canada, funded by the Government of Canada, which provided $ 1 million through a Transition to
Scale investment and helped catalyze
matching investments from a wide range of sources including Maple Leaf Angels, MaRS Innovation, the University of Toronto's Connaught Seed Fund, the Government of Canada through the
National Research Council of Canada Industrial Research Assistance Program (NRC - IRAP) and the Scientific Research and Experimental Development Tax Incentive Program (SR&ED), and the Government of Ontario through investment by Ontario Centres of Excellence and support by MaRS Discovery District and ventureLAB / Genesis.
«Large -
scale clinical sequencing and molecular profiling can better inform collaborative programs such as the
National Cancer Institute - Children's Oncology Group Pediatric
MATCH clinical trials and the Pacific Neuro - Oncology Consortium.
Small firms worry about hyper efficient, large
scale competitors with a resource base,
national reach, consumer brand and technology platform that they simply can't
match.